Semagacestat's fall: where next for AD therapies?

Nat Med. 2013 Oct;19(10):1214-5. doi: 10.1038/nm.3365.
No abstract available

MeSH terms

  • Alanine / analogs & derivatives
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism
  • Amyloid Precursor Protein Secretases / antagonists & inhibitors*
  • Azepines
  • Humans

Substances

  • Azepines
  • N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide
  • Amyloid Precursor Protein Secretases
  • Alanine